# Topical Amethocaine Gel for Intramuscular Injection in Term Neonates

> **NCT00267111** · PHASE2 · COMPLETED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 110 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Eucerin plus
- **DRUG:** Amethocaine gel 4%

## Key facts

- **NCT ID:** NCT00267111
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2024-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267111, "Topical Amethocaine Gel for Intramuscular Injection in Term Neonates". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00267111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
